Alas, there is a commercial deal in existence and that is the one with Pacific Edge.
Currently there are at least seven different trials being undertaken in Australia to validate the efficiency of cxbladder, some of which are based on a head to head with the gold standard which is cystoscopy.
Research: Midkine Controls Arteriogenesis by Regulating VEGFA Bioavailability and NOS Expression, page-5
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1197315 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 109888 | 2 |
View Market Depth
| Last trade - 16.12pm 16/08/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable